在不同的混合条件下对阿米奥达龙和富洛塞米德兼容性的比较评估
So Iwabuchi1,2, Toru Imai2, Naoto Suzuki3
1School of Pharmacy Laboratory of Pharmacology , Nihon University , Chiba, Japan.
Scientific reports
|October 17, 2025
概括
混合途径显著影响阿米奥达龙和富罗塞米德的兼容性. 路线混合 (RM) 与模拟混合 (SM) 相比,增加了沉风险,突出了需要在重症监护病房进行谨慎管理,以防止导管并发症.
科学领域:
- 制药科学 制药科学
- 临床药房 临床药房
- 药物兼容性研究 药物兼容性研究
背景情况:
- 阿米奥达龙和富罗塞米德通常在重症监护病房联合使用.
- 它们的不兼容性可能导致沉和导管封闭,对患者的安全构成风险.
研究的目的:
- 调查不同混合程序 (模拟混合与路径混合) 对阿米奥达龙和富罗西米德物理兼容性的影响.
- 在临床相关条件下评估兼容性,以确保安全的静脉注射药物治疗.
主要方法:
- 在治疗度下制备药物混合物.
- 使用视觉检查,吸收度测量,粉末X射线衍射 (PXRD),pH分析和颗粒大小评估进行评估.
- 模拟混合 (SM) 和路线混合 (RM) 程序之间的比较.
主要成果:
- 与模拟混合 (SM) 样本相比,路线混合 (RM) 样本表现出更大的度和更大的颗粒大小.
- 沉物包括已知的富洛塞米德和阿米奥达龙化的多态;没有形成新的晶体物质.
- pH转向性,注射量和furosemide剂量增加.
结论:
- 混合途径显著影响阿米奥达龙-富洛塞米德的兼容性,RM带来了较高的降水风险.
- 在实际的临床管理条件下评估药物兼容性对于预防导管相关并发症和提高患者安全至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796
Renal Failure: Dose Adjustments
434
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
434
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
207
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
207
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
232
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
232
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177


